Artiva Biotherapeutics Inc (ARTV)

Finanzdaten der Artiva Biotherapeutics Inc-Aktie (ARTV)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	10.07%26.89	24.43	21.93	22.90	22.81
Research and Development	13.53%21.93	19.31	16.99	17.63	17.86
Operating Income/Loss	10.07%-26.89	-24.43	-21.93	-22.90	-22.81
Nonoperating Income/Loss	106.24%1.89	0.91	1.16	1.37	1.56
	6.33%-25.01	-23.52	-20.77	-21.53	-21.25
Attributable To Parent	6.33%-25.01	-23.52	-20.77	-21.53	-21.25
Basic Average Shares	59.71%39.41	24.68	0.04	24.48	24.38
Diluted Average Shares	59.71%39.41	24.68	0.04	24.48	24.38
Basic Earnings Per Share	33.68%-0.63	-0.95	-0.84	-0.88	-0.87
Diluted Earnings Per Share	33.68%-0.63	-0.95	-0.84	-0.88	-0.87